BioMark Diagnostics (TSE:BUX)
CNQX:BUX
Holding TSE:BUX?
Track your performance easily

BioMark Diagnostics (BUX) Stock Price & Analysis

3 Followers

BUX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

55.86%44.14%
55.86% Insiders
― Other Institutional Investors
44.14% Public Companies and
Individual Investors

BUX FAQ

What was BioMark Diagnostics’s price range in the past 12 months?
BioMark Diagnostics lowest stock price was C$0.20 and its highest was C$0.32 in the past 12 months.
    What is BioMark Diagnostics’s market cap?
    Currently, no data Available
    When is BioMark Diagnostics’s upcoming earnings report date?
    BioMark Diagnostics’s upcoming earnings report date is Nov 28, 2024 which is in 18 days.
      How were BioMark Diagnostics’s earnings last quarter?
      Currently, no data Available
      Is BioMark Diagnostics overvalued?
      According to Wall Street analysts BioMark Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does BioMark Diagnostics pay dividends?
        BioMark Diagnostics does not currently pay dividends.
        What is BioMark Diagnostics’s EPS estimate?
        BioMark Diagnostics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does BioMark Diagnostics have?
        BioMark Diagnostics has 90,886,230 shares outstanding.
          What happened to BioMark Diagnostics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of BioMark Diagnostics?
          Currently, no hedge funds are holding shares in TSE:BUX
          ---

          BioMark Diagnostics Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          BioMark Diagnostics

          Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Revive Therapeutics
          Sernova
          Reliq Health Technologies
          DMG Blockchain Solutions
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis